Left Menu
Development News Edition

Brazil approves human trials for third COVID-19 vaccine

A vaccine developed by the University of Oxford and AstraZeneca entered clinical trials in Brazil in June. The country is also scrambling to secure supplies of potential vaccines, in case they are proven successful.

Reuters | Brasilia | Updated: 22-07-2020 02:26 IST | Created: 22-07-2020 02:25 IST
Brazil approves human trials for third COVID-19 vaccine
Representative Image Image Credit: ANI

Brazil on Tuesday approved clinical trials starting in August for a potential COVID-19 vaccine under joint development by U.S. pharmaceutical company Pfizer and Germany's BioNTech - the third such vaccine to be tested in the country. With more than 2.1 million confirmed cases of the novel coronavirus, Brazil has the world's worst outbreak outside the United States, making it prime testing grounds for vaccines.

"We are proud to have Brazilian volunteers participating in this global effort, which could play a critical role in the fight against COVID-19," said Edson Moreira, who will lead the Pfizer/BioNTech trial, according to a company statement. Brazilian health regulator Anvisa had previously approved trials for possible vaccines developed in the U.K. and China.

On Tuesday, the first Brazilian volunteer was injected with a possible coronavirus vaccine developed by China's Sinovac Biotech in Sao Paulo. A vaccine developed by the University of Oxford and AstraZeneca entered clinical trials in Brazil in June.

The country is also scrambling to secure supplies of potential vaccines, in case they are proven successful. Interim Health Minister Eduardo Pazuello said on Tuesday that negotiations are underway with U.S. biotech firm Moderna Inc for Brazil to get priority in purchasing a potential COVID-19 vaccine the company is developing.

Pazuello said Brazil already has an understanding with AstraZeneca for the firm to deliver 30 million doses of its potential vaccine. Sinovac has agreed to deliver enough vaccine to immunize 60 million Brazilians if its vaccine is proven effective.

Brazil is also developing possible vaccines domestically, which are still in pre-clinical testing stages.


TRENDING

OPINION / BLOG / INTERVIEW

Uganda COVID-19 response: Was off to a good start but reopening dwindled prospects

Uganda has shown success in using health information to enhance efficiency of disease surveillance, reporting and monitoring. The success, however, has critical challenges confronting it as the country resumes normal activities....

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Videos

Latest News

Rose Byrne, Seth Rogen reuniting for Apple comedy 'Platonic'

Rose Byrne and Seth Rogen are re-teaming for Platonic, a comedy series set up at Apple TV Plus. This will be the duos second collaboration together after the 2014 comedy film Neighbors.According to The Hollywood Reporter, the series hails f...

GSK, Sanofi to make 200 mln doses available for COVID-19 vaccine alliance

French drugmaker Sanofi SA and Britains GlaxoSmithKline plan to make 200 million doses of their COVID-19 vaccine candidate available to the vaccine allocation plan co-led by GAVI and the World Health Organization. The companies said on Wedn...

Digitalisation to drive USD 6.8 trillion IT spending from 2020 to 2023: IDC

The global economy remains on its way to its digital destiny driving USD 6.8 trillion of IT spending from 2020 to 2023, according to International Data Corporation IDC. The impacts from COVID-19 pandemic are ubiquitous and affect the many e...

Pompeo calls on Sri Lankan president; holds bilateral talks with counterpart

US Secretary of State Mike Pompeo on Wednesday called on Sri Lankan President Gotabaya Rajapaksa and discussed a range of bilateral issues, including economic partnership based on transparent trade and investment, COVID-19 as well as a shar...

Give Feedback